Ask AI
ProCE Banner Activity

Lessons From Brazil: Coordinating Rapid-Start PrEP

Clinical Thought

The primary challenge of HIV prevention is not clinical efficacy, but reaching and engaging people most likely to benefit. Read on to learn how Brazil provides an example of how to simplify PrEP delivery with rapid starts and supportive public policy, and see how these principles may be applied to other low- and middle-income countries. 

Released: September 16, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals (both specialists and generalists) who provide PrEP.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply current IAS-USA and CDC guideline recommendations to determine when rapid or same-day PrEP is appropriate

  • Implement efficient, safe, and sustainable clinical workflows that support same day PrEP initiation across varied practice settings

  • Individualize the choice of PrEP modality—oral or long-acting injectable—during same day clinical encounters

Financial Disclosures

Primary Author

Emilia M. Jalil, MD, PhD: consultant/advisor/speaker: Merck Sharp & Dohme.